Mounjaro®
Starting from £179.99/mo
Start journey Learn moreYes, Wegovy can cause burping. Semaglutide slows the rate at which the stomach empties its contents into the small intestine, and that delayed emptying means gas builds up more readily — burping is one of the most commonly reported upper GI effects. It tends to be most noticeable in the first weeks of treatment or after a dose increase, and for most people it settles without needing to stop. Wegovy is a prescription-only medicine; a GPhC-registered prescriber assesses whether it is clinically suitable for you before any treatment begins, which is also the right time to flag any gut symptoms you already experience. The NHS medicines page for semaglutide lists burping and belching among the recognised side effects.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
You started Wegovy, you're following the plan, and now you've noticed something nobody mentioned: you burp. A lot. After meals, sometimes between them. It feels odd, maybe embarrassing, and a small voice wonders whether the medicine is doing something wrong.
It isn't. Semaglutide works partly by activating GLP-1 receptors in the gut wall, which tells the stomach to hold food for longer before releasing it into the small intestine. That slower transit is what reduces appetite and steadies blood sugar, but it is also why gas accumulates in the stomach and finds the nearest exit. If you want a closer look at why this happens, our page on burping and semaglutide walks through the mechanism in more detail. Burping is essentially a mechanical consequence of that delay, not a sign of damage or intolerance.
The effect is dose-dependent, which is why the titration schedule exists. Starting at a low dose and stepping up gradually gives the gut time to adapt at each level. Most people find the burping is worst in the first one to two weeks after a dose change, then eases. Some people barely notice it at all. A smaller group find it persists longer, particularly if they have a pre-existing tendency towards reflux. If that sounds like you, it is worth mentioning to your prescriber before treatment begins rather than discovering it three weeks later.
You can read more about the full picture of Wegovy's side-effect profile to understand where burping sits alongside other GI effects.
A common assumption is that burping on Wegovy means the medicine is sitting in the stomach undigested, or that the injection site has something to do with it. Neither is the case. Semaglutide is absorbed subcutaneously and acts on receptors; the burping happens because of what the medicine does to stomach motility, not because of any local reaction to the injection. Once that's clear, it tends to feel less alarming. Our dedicated page on Wegovy burping covers why this reaction is more common than most people expect and what tends to make it better or worse.
What does make a difference is how you eat. Large meals push more volume into an already slower-emptying stomach, giving gas more opportunity to form. Eating quickly means swallowing more air. Carbonated drinks add CO₂ directly. None of these are unique to Wegovy (they'd cause burping in anyone) but semaglutide amplifies the effect because gastric emptying is already taking longer than usual.
Practical adjustments that consistently help: eat smaller portions more slowly, wait a few minutes between bites, cut back on fizzy drinks while you are in the early weeks of a new dose, and avoid lying flat immediately after meals. These are not dramatic life changes. They are the kind of thing a pharmacist would mention before you'd even finished asking the question.
Our frequently asked questions cover a range of Wegovy queries if you want answers to specific concerns beyond the burping.
For the vast majority of people, burping on Wegovy is a nuisance, not a medical concern. It resolves on its own as the gut adapts, and it does not affect how well the medicine works.
There are situations, though, where it warrants a conversation with your prescriber rather than a wait-and-see approach. If the belching comes with persistent upper abdominal pain or a burning sensation that does not settle, that could indicate gastro-oesophageal reflux being exacerbated by slowed emptying. If you develop severe, persistent stomach pain that spreads towards the back, that is a different matter entirely: the MHRA's Yellow Card scheme flags acute pancreatitis as a serious but infrequent risk with GLP-1 medicines, and pain of that character needs prompt medical assessment, not watchful waiting.
Burping alone, without those accompanying symptoms, is not a red flag. But your prescriber is the right person to distinguish between normal adjustment and something that needs managing, which is exactly why clinical review continues beyond the first prescription. Our clinical team reviews every repeat order, not just the initial consultation.
If you are comparing how this side effect differs across GLP-1 options, our overview of whether semaglutide causes burping and the broader question of excessive burping on Wegovy both go into more detail. For context on what Wegovy treatment involves from the start, our Wegovy overview page covers eligibility, dosing stages, and what the prescription process looks like.
Wegovy is a prescription-only medicine, and a clinician decides suitability based on your full health picture. If you'd like to understand your options, you're welcome to start your free consultation with our prescribers.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.